Life expectancy of myeloma patients after autologous stem cell transplant?

Myeloma . There are many things that go into predicting life expectancy of somebody with myeloma who has an autologous stem cell transplant. The rough estimate for somebody getting a transplant in first remission is about 6-7 years now. However, this is something your oncologist or transplant doctor can talk to you about with more specific information.

Related Questions

Is it reasonable to have second autologous stem cell transplant for myeloma?

Yes. This is a very difficult question today because every situation with myeloma is different. We do not double transplant all myeloma patients like we have done in the past. It is sometimes reasonable if the first was previously successful and donor cells remain. We now have so many treatments for myeloma that sometimes we do an allogeneic transplant or treat with other drugs (velcade, carfilzomab. Read more...

What is an autologous stem cell transplant and am I a candidate for one?

Means of treatment. In some cases, the best way to treat the disease, especially if it has come back after initial treatment is to use doses of chemotherapy or radiation which is high enough to destroy normal bone marrow cells. To "rescue" these cells, they are stimulated with drugs before high dose therapy that cause very immature cells called stem cells to enter the blood where they can be collected and given back. Read more...
Autologous stem cell. An autologous stem cell transplant is the process of removing a stem cell source tissue from your own body, isolating the stem cells from that tissue, and reinjecting the isolated cells back into your own body. Only your attending physician or the primary investigator of your study could answer that question! however, the issue is safety and efficacy, as you should not have any rejection issues. Read more...

I am going to have an autologous stem cell transplant what is my survival rate?

About 97% In a standard risk situation only 2-3% of patients die from complications related to the transplant. The intermediate and long term survival is a function of the underlying disease and thus comment is not possible without the entire clinical context. Read more...

What is the goal/ predicted outcome of autologous stem cell transplantation studies for ms?

Multiple sclerosis . Researchers are optimistic. Yet, no proven efficacy as of yet. Mortality is down to 1-2%. Check following site: http://www.Ncbi.Nlm.Nih.Gov/m/pubmed/18565456/. Read more...
Research continues. Idea of stem cells is to restore areas of prior damage from ravages of the disease. We still are far away from using this approach. Regarding your status, do not see a specific MS disease modifying drug on your list. Am not clear about use of IVIG, is it for immunoglobulin deficiency, as certainly NO benefit in treatment of MS? Hopefully, you have a neurologist. Discuss future plans. Read more...

When Stem Cell Transplant Therapy will be used to cure or Improve MS patients? Why every cure took so long to use for patients? Please find the cure.

Be careful. This is being promoted to desperate people. It is very expensive and if it has any benefit, it's not obvious. The theoretical considerations these folks have offered don't square that well with what I know about the disease. More generally, progress in therapy would proceed faster if the public accepted more risks in trials of new treatments -- but that's for the lawyers and ethicists. Read more...